[1]
Gosain R,Mukherjee S,Yendamuri SS,Iyer R, Management of Typical and Atypical Pulmonary Carcinoids Based on Different Established Guidelines. Cancers. 2018 Dec 12; [PubMed PMID: 30545054]
[2]
Rosado de Christenson ML,Abbott GF,Kirejczyk WM,Galvin JR,Travis WD, Thoracic carcinoids: radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 1999 May-Jun; [PubMed PMID: 10336200]
[3]
Swarts DR,Ramaekers FC,Speel EJ, Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochimica et biophysica acta. 2012 Dec; [PubMed PMID: 22579738]
[4]
Stankovic B,Aamodt H,Bjørhovde HAK,Müller E,Hammarström C,Brustugun OT,Helland Å,Øynebråten I,Corthay A, The immune microenvironment in typical carcinoid lung tumor, a brief report of four cases. Scandinavian journal of immunology. 2020 May 20; [PubMed PMID: 32433774]
[5]
Hemminki K,Li X, Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer. 2001 Oct 15; [PubMed PMID: 11596039]
[6]
Quaedvlieg PF,Visser O,Lamers CB,Janssen-Heijen ML,Taal BG, Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2001 Sep; [PubMed PMID: 11697843]
[7]
Yao JC,Hassan M,Phan A,Dagohoy C,Leary C,Mares JE,Abdalla EK,Fleming JB,Vauthey JN,Rashid A,Evans DB, One hundred years after [PubMed PMID: 18565894]
[8]
Kayser K,Kayser C,Rahn W,Bovin NV,Gabius HJ, Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. Journal of surgical oncology. 1996 Oct; [PubMed PMID: 8888802]
[9]
Saber M,Ismail Y,Alieldin N,Loay I,El Zawahry M, Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014). Journal of the Egyptian National Cancer Institute. 2018 Dec; [PubMed PMID: 30470605]
[11]
Zeng Y,Zhu Y,Ding Y,Xu L,Zhai B,Zhang X,Ge Q,Li J,Song Q,Li X,Zhang Z, Analysis of lung biopsies using the 2015 WHO criteria and detection of sensitizing mutations--a single-institution experience of 5032 cases. Diagnostic pathology. 2020 May 19; [PubMed PMID: 32429938]
[12]
Ferolla P, Medical treatment of advanced thoracic neuroendocrine tumors. Thoracic surgery clinics. 2014 Aug; [PubMed PMID: 25065936]
[13]
Caplin ME,Baudin E,Ferolla P,Filosso P,Garcia-Yuste M,Lim E,Oberg K,Pelosi G,Perren A,Rossi RE,Travis WD, Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Aug; [PubMed PMID: 25646366]
[14]
Filosso PL,Rena O,Donati G,Casadio C,Ruffini E,Papalia E,Oliaro A,Maggi G, Bronchial carcinoid tumors: surgical management and long-term outcome. The Journal of thoracic and cardiovascular surgery. 2002 Feb; [PubMed PMID: 11828290]
[15]
Queiroz RM,Santana DBF,Nastri Filho R,Landell GAM,Félix PR,Valentin MVN, Endobronchial carcinoid tumor: Radiological findings of a clinical case. Revista da Associacao Medica Brasileira (1992). 2018 Jan; [PubMed PMID: 29561937]
[16]
Daniels CE,Lowe VJ,Aubry MC,Allen MS,Jett JR, The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest. 2007 Jan; [PubMed PMID: 17218584]
[17]
Venkitaraman B,Karunanithi S,Kumar A,Khilnani GC,Kumar R, Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid. European journal of nuclear medicine and molecular imaging. 2014 May; [PubMed PMID: 24435773]
[18]
Erasmus JJ,McAdams HP,Patz EF Jr,Coleman RE,Ahuja V,Goodman PC, Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR. American journal of roentgenology. 1998 May; [PubMed PMID: 9574618]
[19]
Lim E,Yap YK,De Stavola BL,Nicholson AG,Goldstraw P, The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. The Journal of thoracic and cardiovascular surgery. 2005 Oct; [PubMed PMID: 16214506]
[20]
Naalsund A,Rostad H,Strøm EH,Lund MB,Strand TE, Carcinoid lung tumors--incidence, treatment and outcomes: a population-based study. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2011 Apr; [PubMed PMID: 20888248]
[21]
Crocetti E,Paci E, Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2003 Jun; [PubMed PMID: 12771556]
[22]
Steuer CE,Behera M,Kim S,Chen Z,Saba NF,Pillai RN,Owonikoko TK,Khuri FR,Ramalingam SS, Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2015 Mar; [PubMed PMID: 25371080]